Nano-X Imaging to launch FDA-cleared Nano.ARC X, present developments at RSNA

Nano-X Imaging (NNOX) announced that it will showcase its Nanox.ARC X multi-source digital tomosynthesis system and highlight development of new solutions for its AI portfolio at the Radiological Society of North America, RSNA, 2025 Annual Meeting, being held November 30 – December 4, 2025 in Chicago, IL. The Nanox.ARC X received FDA 510(k) clearance in April 2025 for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications. At RSNA 2025, attendees will have their first opportunity to see live demonstrations of the system. Nanox will showcase its full end-to-end imaging solution, which includes the Nanox.ARC X and its suite of FDA-cleared, AI-powered software that analyzes routine CT scans to identify early signs of chronic conditions.